| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.3B | $0.2B | $0.2B | $0.2B | $0.3B | $0.2B | $0.2B | $0.1B |
| EPS (Basic) | $2.03 | $2.29 | $2.53 | $2.97 | $3.26 | $1.93 | $2.41 | $2.22 |
| EPS (Diluted) | $2.03 | $2.24 | $2.53 | $2.97 | $3.26 | $1.93 | $2.41 | $2.22 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $37.6B | $24.6B | $21.2B | $20.5B | $20.1B | $19.6B | $17.6B | $13.8B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $1.0B | $0.4B | $0.4B | $0.3B | $0.8B | $0.5B | $0.4B | $0.3B |
| Total Liabilities | $32.6B | $21.4B | $18.6B | $18.1B | $17.4B | $16.9B | $15.0B | $11.8B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $5.0B | $3.1B | $2.6B | $2.4B | $2.7B | $2.7B | $2.5B | $1.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.2B | $0.3B | $0.3B | $0.4B | $0.3B | $0.2B | $0.2B | $0.2B |
| Investing Cash Flow | $-0.8B | $-0.3B | $-0.6B | $-1.3B | $-0.3B | $-1.9B | $-0.4B | $-0.8B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.8B | $-0.0B | $0.4B | $0.4B | $0.3B | $1.7B | $0.4B | $0.6B |